Yukon Choice PC
6Pages

{{requestButtons}}

Catalog excerpts

Yukon Choice PC - 1

Sirolimus Eluting Coronary Stent System Translumina – Prevent your Stent Thrombosis

Open the catalog to page 1
Yukon Choice PC - 2

Yukon® Choice PC Excellent Long-Term Clinical Outcome The Translumina Yukon Choice PC drug-eluting stent, coated with Rapamycin (Sirolimus) and the biodegradable components polylactide and shellac, has an excellent history of pre-clinical and clinical results.[1,2] In two independent trials ISAR-TEST 3 and ISAR-TEST 4 the Yukon Choice PC showed angiographic and clinical equivalence with the Cypher stent after 1 year and 3 years of follow-up.[3,4] Latest clinical data, published by G.Stefanini et al [5], show the excellent long-term outcome of the Yukon Choice PC in a meta-analysis,...

Open the catalog to page 2
Yukon Choice PC - 3

Pre-Clinical Data [ 1 ] Extensive pre-clinical evaluations prove the safety of Yukon Choice PC over BMS and conventional DES: Sirolimus [ng/mg tissue] Sirolimus release [%] vascular tissue prevascular tissue Yukon Choice PC shows a release of sirolimus up to 4 weeks with a significant tissue concentration in the arterial segments. Yukon Choice PC shows a reduced neointimal formation compared to a bare metal stent without compromising vascular healing. Safety of the BMS Platform [  2  ] The microporous surface of the Yukon Choice PC is well studied for its efficacy and safety when compared...

Open the catalog to page 3
Yukon Choice PC - 4

Efficacy [  3,4  ] The ISAR-TEST 4 is the first prospective randomized trial which compares different DES i.e. Yukon Choice PC, Xience and Cypher for their efficacy & safety in over 2600 patients. Target lesion revascularization (%) Target lesion revascularization (%) Xience && Cypher 20,9% Xience Cypher 20,9% Yukon Choice PC 20,1% Yukon Choice PC 20,1% Xience && Cypher 14,2% Xience Cypher 14,2% Yukon Choice PC 13,9% Yukon Choice PC 13,9% Month after randomization Month after randomization Month after randomization Month after randomization The Yukon Choice PC with biodegradable polymer...

Open the catalog to page 4
Yukon Choice PC - 5

Yukon® Choice PC Sirolimus Eluting Coronary Stent System The Biodegradable Polymer DES now with a lot of new features The new distal shaft Our high performance shaft consisting of a new material provides excellent pushability and kink resistance. This feature allows for high manoeuvrability. The new stent delivery system The new flexible tip The new designed luer The transparent luer has a positive, tactile feel assisting in navigation of the system. It is designed with an integrated protection to minimize any kinking. The soft tip material combined with an improved robust segment ensures...

Open the catalog to page 5
Yukon Choice PC - 6

Sirolimus Eluting Coronary Stent System Yukon® Choice PC Product matrix / Ordering information* Balloon Stent length [mm] & Article number 8 Stent length [mm] & Article number * Please contact our customer service for available sizes Compliance chart Inflation pressure [bar or 10 - 5 Pascal] NP © 013 Translumina GmbH 2 All Rights Reserved ® Yukon, Yukon Choice, Pearl Surface and Translumina are registered trademarks of translumina GmbH Please refer to the Instruction for Use supplied with these devices for indications, contraindications, adverse effects, suggested procedures, warnings and...

Open the catalog to page 6

All Translumina catalogs and technical brochures

  1. Cathy No. 4

    4 Pages

  2. YUKON CC

    4 Pages